Tmax, drop-outs (EMA) [Regulatives / Guidelines]

posted by pash413 – India, 2012-03-28 19:04 (4383 d 03:37 ago) – Posting: # 8345
Views: 4,992

Dear HS
Thanks for your quick reply
  1. Our formulation is IR formulation, but the reported Tmax is around 6-10 hours.
  2. Further we want to know the the reason/regulatory expectation behind the analysing the drop out/ withdrawal subjects. Will it be useful to establish any correlation between adverse events with the plasma concentration data and may be used to rule out formulation performance as the reason of adverse events? then what about it's applicability for subject who dropout due to personal reason? Please share your view, as USFDA does not require analysis of such dropout subjects.

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
82 visitors (0 registered, 82 guests [including 8 identified bots]).
Forum time: 21:42 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5